IL2 and neoplasm: In line herewith, Viey et al. demonstrated γδ T cell expansion out of tumor-infiltrating lymphocytes of renal cell carcinoma patients with bromohydrin pyrophosphate, a synthetic phosphoantigen, in combination with IL-15, while the combination with IL-2 was inefficient [5].